OSI archive

English

Post

New medicine for two types of pulmonary fibrosis

· May 23, 2026

EMA has recommended granting a marketing authorisation in the European Union (EU) for Jascayd (nerandomilast) to treat adults with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF), two serious...

Post

Ten years of the GDPR: your data, your rights

· May 23, 2026

About usAbout usLearn more about the role of the European Commission, its leadership and corporate policies Our prioritiesOur prioritiesLearn how the EU is building a sustainable, digital, and inclusive future...